HuagongsheHuagongshe Chemistry Print Report · For research reference only
[4-(Piperazin-1-yl)phenyl]boronic acid → N-(cyanomethyl)-4-methyl-2-[(4'-piperazin-1-yl-1,1'-biphenyl-4-yl)(pyridin-2-yl)methoxy]pentanamide
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | [4-(Piperazin-1-yl)phenyl]boronic acid | HCID 5233013 | — |
| Reactant | 2-[(4-bromophenyl)(pyridin-2-yl)methoxy]-N-(cyanomethyl)-4-methylpentanamide | HCID 10319702 | — |
| Product | N-(cyanomethyl)-4-methyl-2-[(4'-piperazin-1-yl-1,1'-biphenyl-4-yl)(pyridin-2-yl)methoxy]pentanamide | HCID 10345777 | — |
Reaction Steps
Using the same protocol as described in example 21, 2-[(4-bromophenyl)(pyridin-2-yl)methoxy]-N-(cyanomethyl)-4-methylpentanamide from example 7, step 4 (241 mg, 0.58 mmol) was coupled with 4-piperazin-1-ylphenylboronic acid (155 mg, 0.64 mmol). The crude residue obtained was chromatographed on silica gel using 1% NH4OH and 9% MeOH in dichloromethane to afford the title compound.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US07279478B2 |
| Source dataset | uspto-grants-2007_10 |
| ORD ID | ord-63ba42273a044aa68cb73251b8a012d2 |
| Source note | uspto-grants-2007_10 |